Published in Neuropharmacology on September 25, 2013
The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron (2014) 1.59
Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases. Eur J Neurosci (2015) 1.52
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochem Pharmacol (2014) 1.01
Neuroinflammation in Alzheimer's disease. Neuropsychiatr Dis Treat (2015) 1.01
The role of extracellular Tau in the spreading of neurofibrillary pathology. Front Cell Neurosci (2014) 0.95
Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. J Alzheimers Dis (2015) 0.93
New Features about Tau Function and Dysfunction. Biomolecules (2016) 0.84
Thermodynamics of the interaction between Alzheimer's disease related tau protein and DNA. PLoS One (2014) 0.83
Exercise, cognitive function, and aging. Adv Physiol Educ (2015) 0.81
The associations between Parkinson's disease and cancer: the plot thickens. Transl Neurodegener (2015) 0.81
Tau and spectraplakins promote synapse formation and maintenance through Jun kinase and neuronal trafficking. Elife (2016) 0.79
Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's model. PLoS One (2014) 0.78
Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer's disease correlates with pathology. Acta Neuropathol Commun (2014) 0.78
Synaptic activity and Alzheimer's disease: a critical update. Front Neurosci (2015) 0.78
Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition. J Cereb Blood Flow Metab (2016) 0.77
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease. Acta Neuropathol Commun (2016) 0.76
Involvement of 'stress-response' kinase pathways in Alzheimer's disease progression. Curr Opin Neurobiol (2014) 0.76
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain (2017) 0.75
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease. Oxid Med Cell Longev (2016) 0.75
Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation. Cell Death Dis (2016) 0.75
Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases. J Alzheimers Dis (2017) 0.75
Increased extrasynaptic GluN2B expression is involved in cognitive impairment after isoflurane anesthesia. Exp Ther Med (2016) 0.75
Role of P2X7 and P2Y2 receptors on α-secretase-dependent APP processing: Control of amyloid plaques formation "in vivo" by P2X7 receptor. Comput Struct Biotechnol J (2015) 0.75
Imidazo[2,1]thiazol-3-one Derivatives Useful as Diagnostic Agents for Alzheimer's Disease. ACS Med Chem Lett (2014) 0.75
Association of DISC1 Polymorphisms with Late-Onset Alzheimer's Disease in Northern Han Chinese. Mol Neurobiol (2016) 0.75
Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies. Oncotarget (2017) 0.75
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med (2009) 2.39
Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep (2013) 1.57
Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J Biol Chem (2008) 1.38
Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo. J Neurosci (2003) 1.36
Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J Cell Sci (2004) 1.36
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J Neurosci (2005) 1.35
Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism. FASEB J (2007) 1.24
Molecular motors implicated in the axonal transport of tau and alpha-synuclein. J Cell Sci (2005) 1.20
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J Neurochem (2007) 1.20
Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol (2002) 1.16
Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol Aging (2011) 1.13
Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J (2008) 1.11
Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease. FASEB J (2008) 1.08
The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol (2013) 1.05
Anti-inflammatory impact of minocycline in a mouse model of tauopathy. Front Psychiatry (2010) 1.03
Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aβ production. Hum Mol Genet (2012) 1.02
Tau phosphorylation affects its axonal transport and degradation. Neurobiol Aging (2013) 1.00
Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Neurobiol Aging (2011) 0.99
Organotypic slice cultures from transgenic mice as disease model systems. J Mol Neurosci (2002) 0.98
Kinase activities increase during the development of tauopathy in htau mice. J Neurochem (2007) 0.98
Functional implications of the association of tau with the plasma membrane. Biochem Soc Trans (2010) 0.95
Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding. Prion (2009) 0.94
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int J Alzheimers Dis (2011) 0.94
The microtubule-associated protein tau is also phosphorylated on tyrosine. J Alzheimers Dis (2009) 0.94
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. J Neurochem (2008) 0.93
Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev Neurother (2009) 0.92
Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. FEBS J (2011) 0.91
Linking amyloid and tau pathology in Alzheimer's disease: the role of membrane cholesterol in Abeta-mediated tau toxicity. J Neurosci (2009) 0.90
Isolation of detergent resistant microdomains from cultured neurons: detergent dependent alterations in protein composition. BMC Neurosci (2010) 0.89
The microtubule-associated protein tau is phosphorylated by Syk. Biochim Biophys Acta (2007) 0.86
NUB1 modulation of GSK3β reduces tau aggregation. Hum Mol Genet (2012) 0.86
Neurodegeneration as an RNA disorder. Prog Neurobiol (2012) 0.85
Advances in tau-based drug discovery. Expert Opin Drug Discov (2011) 0.83
Prostate-derived sterile 20-like kinases (PSKs/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer disease. J Biol Chem (2013) 0.82
Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease. Aging Cell (2013) 0.79
Key issues in the acquisition and analysis of qualitative and quantitative mass spectrometry data for peptide-centric proteomic experiments. Amino Acids (2012) 0.79
Loss of c-Jun N-terminal kinase-interacting protein-1 does not affect axonal transport of the amyloid precursor protein or Aβ production. Hum Mol Genet (2013) 0.79
Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β. Biol Open (2014) 0.77